+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SANDUPHQ SANDUPHQ

Sandu Pharmaceuticals Share Price

₹39.84 +1.36 (3.53%)
31.64% Fall from 52W High

07 Aug, 2026 1:26 PM (IST)

Sandu Pharmaceuticals live price: ₹39.84. It opened at ₹41 vs previous close ₹39; intraday high/low: ₹41/₹40. The 50 & 200 DMA stand at ₹40.20/₹41.00.

Sandu Pharmaceuticals Performance

  • Today's Low
  • ₹40
  • Today's High
  • ₹41
  • 52 Week Low
  • ₹30
  • 52 Week High
  • ₹58
  • Open Price₹41
  • Previous Close₹39
  • Volume535
  • 50 DMA₹40.20
  • 100 DMA₹40.00
  • 200 DMA₹41.00

Sandu Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -4.96%
  • Over 3 Month -4.92%
  • Over 6 Month + 17.8%
  • Over 1 Year -16.53%

Smart Investing Starts Here Start SIP with Sandu Pharmaceuticals for Steady Growth!

Invest Now

Sandu Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 15.9
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 39
  • P/B Ratio
  • 0.9
  • Average True Range
  • 1.7
  • EPS
  • 2.5
  • Dividend Yield
  • 2
  • MACD Signal
  • -0.5
  • RSI
  • 43.44
  • MFI
  • 65.49

Latest Stock News Updates

Sandu Pharmaceuticals Ltd - 524703 - Board Meeting Intimation for To Consider And Approve The Standalone Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2026.

Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1.To consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June, 2026. 2.To consider any other matter with the permission of the Chair

Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders

Reconstitution of Committees of Board-Audit/Nomination/Stakeholders

Sandu Pharmaceuticals Ltd - 524703 - Announcement under Regulation 30 (LODR)-Change in Directorate

1.Appointment of Dr Neeti Madan Kapre (DIN:06801264) as additional Non Executive Independent Director of the Company 2.Redesignation of Shri Balram Viswanathan (DIN: 10245195) as Chairman and Managing Director of the Company

Sandu Pharmaceuticals Financials

Sandu Pharmaceuticals Technicals

EMA & SMA

Current Price
₹39.84
+ 1.36 (3.53%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹39.80
  • 50 Day
  • ₹40.20
  • 100 Day
  • ₹40.00
  • 200 Day
  • ₹41.00

Resistance and Support

40.21 Pivot Speed
  • R3 42.50
  • R2 41.60
  • R1 40.00
  • S1 37.50
  • S2 36.60
  • S3 35.00

Sandu Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-11 Quarterly Results
2026-07-11 Others Inter-alia, to consider 1. To place on record the demise of Shri Umesh B. Sandu Managing Director of the Company. 2. Approve the reconstitution of the Committees of the Board. 3.Other business matters
2026-05-05 Audited Results & Final Dividend
2026-02-06 Quarterly Results
2025-11-12 Quarterly Results
Date Purpose Remarks
2025-09-18 FINAL Rs.0.80 per share(8%)Final Dividend
View Sandu Pharmaceuticals Dividend History Arrow

Sandu Pharmaceuticals Shareholding Pattern

62.2%
37.79%
0.01%

About Sandu Pharmaceuticals

Sandu Pharmaceuticals is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. e company has its manufacturing plant in Goa. View More
  • NSE Symbol
  • SANDUPHQ
  • BSE Symbol
  • 524703
  • ISIN
  • INE751D01014

Similar Stocks to Sandu Pharmaceuticals

Sandu Pharmaceuticals FAQs

Sandu Pharmaceuticals share price is ₹39 As on 07 August, 2026 | 13:27

The Market Cap of Sandu Pharmaceuticals is ₹38.5 Cr As on 07 August, 2026 | 13:27

The P/E ratio of Sandu Pharmaceuticals is 15.9 As on 07 August, 2026 | 13:27

The PB ratio of Sandu Pharmaceuticals is 0.9 As on 07 August, 2026 | 13:27

The 52 week High & Low of Sandu Pharmaceuticals is ₹58.3/₹30 respectively As on 07 August, 2026 | 13:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23